Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation. [Phase 2]
Pfizer reports Phase 2 results evaluating four dosing regimens of CP-526,555 versus placebo for smoking cessation over 12 weeks, focusing on…
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation [Phase 2]
A Phase 2 trial from Pfizer evaluated the safety and efficacy of three doses of CP-526,555 versus placebo for smoking cessation over 12 week…
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of flexible dosing of CP-526,555 versus placebo for smoking cessation over 12 weeks.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation [Phase 3]
Phase 3 study evaluating the safety and efficacy of varenicline versus placebo and bupropion (Zyban) for smoking cessation completed over a …
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline [Phase 3]
A completed Phase 3 placebo-controlled trial evaluating the safety of varenicline for smoking cessation over 52 weeks.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation [Phase 3]
Pfizer-sponsored Phase 3 open-label trial compares varenicline to a transdermal nicotine patch for smoking cessation and has completed.
-
FDA approval · 2007-05-24FDA Approved: QUITINE NICOTINE — Original Application (QUITINE LLC)
The FDA approved QUITINE NICOTINE (nicotine polacrilex) via an Original Application (ANDA) submitted by QUITINE LLC. It is a nicotine replac…
-
FDA approval · 2007-05-24FDA Approved: FOSTER AND THRIVE NICOTINE — Original Application (Strategic Sourcing Services LLC)
The FDA approved the original ANDA for Foster and Thrive Nicotine (nicotine polacrilex) from Strategic Sourcing Services LLC, a generic nico…
-
FDA approval · 2007-05-01FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, authorizing the generic product under an …
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: The Effect of Smoking on Perception
A clinical trial update from American University studying the effect of smoking on perception in nicotine dependence; the current trial stat…
-
FDA approval · 2007-03-08FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
The FDA approved Walgreens' supplemental application for Nicotine Polacrilex Mint (nicotine polacrilex), expanding the approved nicotine rep…
-
FDA approval · 2007-03-08FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, expanding its labeling for this nicotine replace…
-
FDA label_change · 2007-03-08FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum Original Flavor to expand labeling with the Original Flavor under …
-
CLINICAL_TRIALS trial_result · 2007-01-31Clinical Trial Update: Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers [NA]
A clinical trial update examining how nicotine affects neurocognitive performance in cigarette smokers; the study status is currently UNKNOW…
-
FDA approval · 2006-12-08FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
FDA approved a supplemental application for Nicotine Polacrilex Mint, adding a mint-flavored nicotine replacement therapy product from Walgr…
-
FDA approval · 2006-12-08FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum Original Flavor, expanding the approved product to include this fl…
-
FDA approval · 2006-12-08FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approves a supplemental application for Rugby Nicotine Polacrillex Gum Original Flavor, maintaining approval for this nicotine replaceme…
-
CLINICAL_TRIALS trial_result · 2006-11-17Clinical Trial Update: Family Consultation for Health-Compromised Smokers [Phase 1]
Phase 1 clinical trial update on family consultation for health-compromised smokers related to nicotine dependence; the trial has completed.
-
FDA approval · 2006-10-30FDA Approved: NICOTINE — Original Application (H E B)
FDA approved the original application for NICOTINE (nicotine polacrilex) gum from H E B, granting approval for this generic nicotine replace…
-
FDA approval · 2006-10-30FDA Approved: EQUATE NICOTINE — Original Application (Wal-Mart Stores Inc)
FDA approved Equate Nicotine under an Original Application (ANDA) by Wal-Mart Stores Inc for nicotine polacrilex gum, a generic nicotine rep…
-
FDA approval · 2006-10-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York's supplemental application for a generic form of bupropion hydrochloride, authorizing it…
-
FDA approval · 2006-09-15FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Sam's West Inc)
FDA approved a supplemental application for the nicotine transdermal system (nicotine patch) filed by Sam's West Inc, updating the product's…
-
CLINICAL_TRIALS trial_result · 2006-06-27Clinical Trial Update: Bupropion Treatment for Youth Smoking Cessation [Phase 3]
Phase 3 trial evaluating bupropion for youth smoking cessation has completed.
-
FDA approval · 2006-06-13FDA Approved: DG HEALTH NICOTINE — Supplemental Application (Dolgencorp Inc)
FDA approved a supplemental application for DG Health Nicotine (nicotine polacrylex) from Dolgencorp Inc under the ANDA. This action updates…
-
FDA approval · 2006-06-13FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex gum), Walmart's store-brand nicotine replacement therapy. T…